CLINICAL_TRIALS
trial_result
· 2012-09-25
Clinical Trial Update: Study of KB003 In Biologics-Inadequate Rheumatoid Arthritis [Phase 2]
Summary
A Phase 2 trial of KB003 for rheumatoid arthritis, sponsored by Humanigen, was terminated and results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Humanigen, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2012-09-25